Diagnostic Ultrasound System (Resona I10W);Diagnostic Ultrasound System (Resona I10 Exp);Diagnostic Ultrasound System (Resona I10);Diagnostic Ultrasound System (Resona I10S);Diagnostic Ultrasound System (Resona XI);Diagnostic Ultrasound System (Resona I10 CV);Diagnostic Ultrasound System (Nuewa I10W);Diagnostic Ultrasound System (Nuewa I10 Exp);Diagnostic Ultrasound System (Nuewa I10);Diagnostic Ultrasound System (Nuewa I10S);Diagnostic Ultrasound System (Nuewa XI);Diagnostic Ultrasoun
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Decision date Oct 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision on 2026-10-08 for K261617, a traditional 510(k) from Shenzhen Mindray Bio-Medical Electronics Co., Ltd. The listed device name covers multiple Diagnostic Ultrasound System configurations under the Resona and Nuewa labels, including I10W, I10 Exp, I10, I10S, XI and I10 CV variants; the name field is truncated in the source, so the full model list is not established here. The application was received 05/15/2026 under regulation 892.1550, classification product code IYN, with subsequent codes ITX and IYO, in the Radiology specialty and review panel.
Substantially equivalent means FDA cleared the submission for marketing; it is not premarket approval of a new device. The record shows a traditional review not performed by a third party, no combination product status and no authorized predetermined change control plan. The summary statement itself is not included in the available text, so the specific indications, technological characteristics and any comparative testing supporting equivalence remain unknown. The page was last updated 11/16/2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261617
- Regulatory pathway
- 510(k) premarket notification
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Oct 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K261617 received
Application receipt date recorded by FDA.
K261617 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K261617
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

